Research

ASEA is changing the way people look at cellular health, and a major factor in that is ongoing research. Check out the latest exciting announcements surrounding the science behind ASEA's groundbreaking products include new findings and expert endorsements.


Redox Certified

BioAgilytix Labs, a leading bioanalytical testing laboratory specializing in biomarker testing, has validated the existence of redox signaling molecules in RENU 28. BioAgilytix works in unison with our internal quality team to give scientific validity to ASEA products and to ensure that every product made is of the highest quality. To maintain its BioAgilytix certification, ASEA provides regular product samples for scientific assay to substantiate the existence of redox signaling molecules. BioAgilytix is a partner of eight of the top 10 global pharma and biotech companies. Half of its employees hold Ph. D. and masters degrees and average 15 years’ post-graduation experience. View Biomarker Details.

Disclaimer: BioAgilytix is a third party website. Although we do our best to make sure that our third-party partners maintain up-to-date information we cannot control and have no responsibility for the availability of information provided on their website at any given time. Having trouble viewing the BioAgilytix website? Click here to view a PDF of the biomarker information.


Facial Skin Study

RENU 28 is active redox signaling molecules that can be applied directly onto the skin to improve and revitalize it at the cellular level. ASEA commissioned a clinical trial to quantify the results of this revitalization. RENU 28 earned Dermatest’s coveted 5-star clinically tested seal for safety, its highest possible commendation. After 4 weeks, the following results were measured:

  • Reduce wrinkle depth by 21%
  • Increase skin elasticity by 20%
  • Improve wrinkles overall by 23%
  • Improve facial skin texture by 22%
  • Increase skin smoothness by 23%
  • Increase skin moisture by 11%

Summary: Within a four week application test carried out by Dermatest GmbH in Muenster, Germany, the effects of RENU 28 to the skin were analyzed under clinically testified criteria on 20 female subjects aged over 45. As a result of this study it was proven that RENU 28 led to an increase in skin hydration and elasticity. A skin-smoothing effect and an improvement in facial appearance was measured after four weeks of application. Over the duration of the study not only measurable but also visible changes could be noticed. Especially the results showing that RENU 28 has an improving effect concerning the reduction of the depth of wrinkles. RENU 28 can be seen to enhance the facial appearance in a natural way. The product does not contain Dermatest Clinically Testedany ingredients that are known to cause any harm to the skin. RENU 28 is therefore a clinically testified, daily skincare product that can also be applied together with other skincare product to support the daily anti-aging skin care routine.

Ordered test conducted by Dermatest® Gmbh, 04.2014.


Cellulite Study

Cellulite forms when fat lobules press against the skin and create a bulge with an accompanying depression next to the bulge. Dermatest completed a 12-week clinical dermatological test which shows that RENU 28 is effective in reducing the appearance of cellulite and improving skin elasticity. After 12 weeks, the following results were measured:

  • 15.81% reduction in the appearance of fat lobule size
  • 20.91% increase in skin elasticity

Summary: Over a 12-week trial period, 30 female participants applied RENU 28 to a cellulite area, using enough product to require 30 – 60 seconds to massage into the skin morning and night. On day one, skin elasticity was measured with a cutometer; fat lobule size measurements were taken with ultrasound images.These results show not only an increase in elasticity, but an actual decrease in the fat itself, and it’s done naturally. RENU 28 works with the body’s natural cellular communication to reduce fat deposits, whereas other treatments for cellulite employ inflammation and the use of fillers for a temporary effect. RENU 28 is being proven to reduce both the appearance and presence of fat deposits.


Cell Turnover Study

Because redox signaling molecules work at a cellular level, with messages that signal cell turnover, ASEA commissioned Stephens & Associates to study the effects of redox signaling on cell turnover, with specific emphasis on the skin. We charged Stephens & Associates to answer this question in their research—Will RENU 28 stimulate skin cell renewal and turnover? After 30 days, the following results were measured for cell turnover:

  • 16% faster skin cell renewal rate

Summary: For the cell turnover study, participants applied RENU 28 to one forearm twice each morning and twice each evening for two weeks. At that point, a fluorescent dye was applied to the RENU 28 forearm and to the control forearm. Each arm was then photographed under UV light and quantified. Over the next two weeks, participants continued to apply RENU 28 as before. The fading of the dye indicated skin cell renewal and turnover. RENU 28 showed 16% faster skin cell renewal rate according to the fading of the dye. Typical cell turnover is 28–42 days. Applying the 16% faster cell turnover rate shown in the study, typical turnover time with RENU 28 is estimated at 24–36 days, shaving four to six days off of normal cell renewal time.


Blood Flow Study

 

As the largest organ in the body in terms of both surface area and weight, the skin protects the body from the elements, regulates body temperature and fluid balance, and is an organ of sensation. All of these functions require proper blood flow. As blood flow decreases with age, a number of conditions can arise. This time we asked Stephens & Associates to answer the following question in their research—Will RENU 28 increase blood flow in the skin? After 30 days, the following blood flow results were measured:

  • 49% blood flow increase within 15 minutes of first application
  • 34% blood flow increase one hour post initial application
  • 35% blood flow increase three hours post initial application
  • 44% blood flow increase 48 hours into the study
  • 55% blood flow increase 96 hours into the study

Summary: For this study, participants applied RENU 28 to one forearm twice each morning and twice each evening. Microcirculation in the skin on each arm was measured with a laser Doppler immediately after RENU 28 application, then again at one hour and three hours. Then, continuing the same morning/night applications, microcirculation was measured at 48 hours and again at 96 hours. The test was performed prior to RENU 28 application each morning so that results for that day would not reflect the latest application.